HRT Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.96M Buy
237,889
+116,825
+96% +$2.76M 0.01% 897
2025
Q4
$3.19M Buy
121,064
+52,603
+77% +$1.15M 0.01% 1010
2025
Q3
$1.17M Buy
68,461
+35,703
+109% +$511K ﹤0.01% 1441
2025
Q2
$411K Sell
32,758
-32,622
-50% -$389K ﹤0.01% 1698
2025
Q1
$778K Sell
65,380
-30,594
-32% -$417K ﹤0.01% 1245
2024
Q4
$1.41M Buy
95,974
+47,166
+97% +$660K 0.01% 901
2024
Q3
$612K Buy
+48,808
New +$531K ﹤0.01% 1494
2023
Q2
Sell
-327,026
Closed -$2.96M 3416
2023
Q1
$2.96M Buy
+327,026
New +$2.85M 0.04% 433
2022
Q3
Sell
-133,794
Closed -$709K 3619
2022
Q2
$709K Buy
+133,794
New +$809K 0.01% 1246

Other funds holding ZYME

HRT Financial's ZYME Position: Q1 2026 in Review

HRT Financial increased its Zymeworks (ZYME) stake by 96% in Q1 2026, buying an estimated $2.76M and bringing the position to 237,889 shares worth $5.96M. The position accounts for 0.01% of the portfolio, ranked #897.

HRT Financial first reported a position in ZYME in Q2 2022 and has held it in 9 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • HRT Financial held 237,889 shares of Zymeworks worth $5.96M as of Q1 2026.
  • HRT Financial bought 116,825 Zymeworks shares in Q1 2026, an estimated $2.76M.
  • Zymeworks made up 0.01% of HRT Financial's portfolio in Q1 2026, its #897 holding.
  • HRT Financial first reported a position in Zymeworks in Q2 2022 and has held it in 9 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.